Crossref
Steroid-limited isatuximab-based quadruplet therapy in elderly, transplant-ineligible multiple myeloma: a REST trial commentary
AME Clinical Trials Review · 2026-04 · 4 · 13-13
DOI: 10.21037/actr-25-81 ↗Kurz gefasst
Fachartikel in der Zeitschrift AME Clinical Trials Review, 2026-04. Verfasst von Dennis D. Lee und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lee, D. D., & Davies, F. E. (2026). Steroid-limited isatuximab-based quadruplet therapy in elderly, transplant-ineligible multiple myeloma: a REST trial commentary. AME Clinical Trials Review, 4, 13-13. https://doi.org/10.21037/actr-25-81
Vancouver
Lee DD, Davies FE. Steroid-limited isatuximab-based quadruplet therapy in elderly, transplant-ineligible multiple myeloma: a REST trial commentary. AME Clinical Trials Review. 2026;4:13-13. doi:10.21037/actr-25-81
BibTeX
@article{Lee2026,
author = {Lee, Dennis D. and Davies, Faith E.},
title = {Steroid-limited isatuximab-based quadruplet therapy in elderly, transplant-ineligible multiple myeloma: a REST trial commentary},
journal = {AME Clinical Trials Review},
year = {2026},
volume = {4},
pages = {13--13},
doi = {10.21037/actr-25-81}
}
EUVIMED